Burning Rock Biotech Limited Deferred Income Tax Expense (Benefit)
Burning Rock Biotech Limited (BNR) reported Deferred Income Tax Expense (Benefit) of CNY 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-04-28
CNY
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | 0.00 CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 0.00 CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 0.00 CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 0.00 CNY 20-F · filed 2025-04-29 |
| 2021-12-31 | 0.00 CNY 20-F · filed 2024-04-29 |
USD
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-28 |
| 2024-12-31 | $0.00 20-F · filed 2025-04-29 |
| 2023-12-31 | $0.00 20-F · filed 2024-04-29 |